Press Releases PolyPid Ltd.

Equities

PYPD

IL0011326795

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-16 pm EDT			5-day change	1st Jan Change
4.44 ^USD	-6.33%		-1.34%	+16.84%

May. 08	Transcript : PolyPid Ltd., Q1 2024 Earnings Call, May 08, 2024
May. 08	PolyPid Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results	May. 08	AQ
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX for the Prevention of Abdominal Colorectal Surgical Site Infections	May. 01	AQ
PolyPid to Participate in Citizens JMP Life Sciences Conference	May. 01	AQ
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections	Apr. 30	AQ
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024	Apr. 24	AQ
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference	Feb. 28	AQ
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 14	AQ
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial	Feb. 12	AQ
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024	Jan. 31	AQ
PolyPid Announces Private Placement for $16 Million in Gross Proceeds	Jan. 04	AQ
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results	Nov. 08	AQ
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors	Nov. 07	AQ
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023	Nov. 01	AQ
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule	23-10-11	AQ
POLYPID : AMENDED AND RESTATED 2012 SHARE OPTION PLAN - Form 6-K	23-10-10	PU
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023	23-10-09	AQ
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX and PLEX Technology Platform	23-10-05	AQ
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform	23-10-04	AQ
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference	23-09-25	AQ
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference	23-09-22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases PolyPid Ltd.

Equities

PYPD

IL0011326795

Press Releases

Filters